Armando Orlandi/photos.asco.org
Jun 1, 2025, 16:52
Armando Orlandi: Racial Disparities in HER2+ Breast Cancer Outcomes at ASCO 2025
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, posted on X:
“Cowabunga! Riding Breast Cancer’s Biggest Data’s Wave from ASCO25
Racial disparities persist with HER2+ ADCs! Asian patients: 89.5% vs Black patients: 80.9% 5-year survival. 83.7% overall 5-year survival impressive, but equity gaps need addressing!”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 28, 2025, 16:22
Jun 28, 2025, 16:07
Jun 28, 2025, 15:34
Jun 28, 2025, 15:15
Jun 28, 2025, 15:15